ArticleCell communication and signaling : CCS2026
P2X4 receptor limits adverse cardiac remodeling following ischemia-reperfusion through regulation of autophagy in cardiac fibroblasts.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPathological ventricular remodeling is an adverse tissue response following acute myocardial infarction (AMI), characterized by an exaggerated fibrosis leading to tissue disorganization and chronic heart failure. Cardiac fibroblasts have a prominent role in the healing process, but also in the fibrosis development, through their differentiation into myofibroblasts, which produce the extracellular matrix, in response to ischemia-reperfusion. Recently, the ATP-gated P2X4 ionotropic receptor has been identified as a key regulator of macro-autophagy, activated under metabolic challenges.
methodsIn this study, we investigated the participation of the P2X4 receptor in the metabolic response of cardiac fibroblasts to ischemia-reperfusion and the myofibroblast switch. To this end, we submitted a primary culture of cardiac fibroblasts to an ischemia-reperfusion simulation and assessed autophagic flux, fibrotic differentiation markers and the correlation to P2X4 expression and activity. Then, using pharmacological inhibition and siRNA-mediated knockdown receptor under-expression, we investigated its role in the response of cardiac fibroblasts to this metabolic challenge. Finally, we validated our findings in an in vivo murine model of coronary ligation in wild-type and P2rx4
resultsOur results reveal that human cardiac fibroblasts subjected to simulated ischemia present an increased autophagic activity associated with a concomitant overexpression of P2X4 and its activity at the plasma membrane of cells. Pharmacological antagonism of P2X4, or its silencing, impaired autophagy, as evidenced by the accumulation of autophagy markers, and induced the expression of fibrotic markers. In an in vivo model of AMI through transient coronary ligation, P2rx4
conclusionsThis study suggests, for the first time, that the P2X4 receptor may contribute to steering cardiac fibroblasts toward a healing-associated profile under ischemia-reperfusion conditions, possibly by modulating autophagic activity and limiting extensive pro-fibrotic differentiation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.